セツキシマブ
1. CetuximabCetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer. When growth factors bind to their receptors on the surface of the cell, the receptors give a signal that causes cells to divide. Some cancers are caused by mutated receptors that give a signal to divide even without growth factor.
Read “Cetuximab” on English Wikipedia
Read “セツキシマブ” on Japanese Wikipedia
Read “Cetuximab” on DBpedia
Read “Cetuximab” on English Wikipedia
Read “セツキシマブ” on Japanese Wikipedia
Read “Cetuximab” on DBpedia
Discussions
Log in to talk about this word.